Connecting research, technology and commercial development across the United States and India.
Bordoloi Biotech was founded in 2012 by Dr. Binoy K. Bordoloi following more than 20 years in the medical device and pharmaceutical industries, including experience at Johnson & Johnson and Baxter Healthcare.
Our mission is to research and develop focused chemistry solutions for unmet needs in biological systems, with an emphasis on inflammation, pain and tissue engineering.
Our work spans technology, intellectual property, new product development and business development. We bring together herbal systems of alternative medicine and modern scientific research, while developing technologies for fibrin longevity, hemostasis and tissue regeneration.
With offices in New Jersey, USA, and New Delhi, India, we seek opportunities for research collaboration, commercialization and patent licensing.
Director & Chief Technology Officer, BBIPL · CEO, BBLLC
An R&D professional with experience spanning nephrology, plasma-derived proteins, wound closure and hemostasis. His career includes leadership and scientific roles at Baxter Healthcare and Johnson & Johnson.
Director · Regulatory Affairs & Quality Assurance
A medical technologist with a background in pharmaceutical sciences, medical devices, quality management, regulatory affairs and clinical affairs, including 22 years at Johnson & Johnson.
Director · Manufacturing & Marketing
Founder of HD Consortium India, a provider of medical and laboratory equipment for diagnostics, with experience in technology transfer and hematology reagent manufacturing in India.
Explore research collaborations, patent licensing and product development.